
August 26 2009 12:00 AM EST
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.

Although protease inhibitors have been shown to interfere with other drugs that are metabolized by the same liver enzymes, a new study shows that methadone -- once suspected to be one of the drugs affected by PIs -- is not adversely affected by the anti-HIV medications. A study in the journal Anesthesiology has shown that methadone is not metabolized by the CYP450 enzyme that PI drugs also use, making methadone-replacement therapy safe for HIVers who are also taking PI-based antiretroviral cocktails. To date, clinicians and HIV patients had been warned that mixing PIs and methadone could lead to abnormally high levels of methadone in the bloodstream and a possible overdose of the medication.